herceptin Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)

Phase 3 (1)

Interventional (1)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadbreast cancer

I am/have/hadmeasurable disease

I am/have/hadstage iv breast cancer

I am/have/hadejection fraction

I am/have/hadabsolute neutrophil count

I am/have/hadaptt

I am/have/hadrecurrent breast cancer

I am/have/hadcreatinine clearance rate

I am/have/hadtargeted therapy

I am/have/hadneutrophil count

added new label for I am/have/had

more

I am looking for

I am looking forherceptin

I am looking fortrastuzumab

I am looking fordocetaxel

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Recruiting

A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.

To evaluate the efficacy,safety and immunogenicity of TQ-B211 plus docetaxel versus Herceptin plus docetaxel in Patients with HER2-positive metastatic breast cancer.Trastuzumab plus docetaxel was chosen as the comparator in the control group,as it represents a common first-line treatment option used in HER2+ MBC population in China.

targeted therapy

creatinine clearance rate

herceptin

measurable disease

trastuzumab

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.